Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa
- PMID: 19710102
- DOI: 10.1177/1753425909106436
Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa
Erratum in
- Innate Immun. 2010 Aug;16(4):273
Abstract
Pseudomonas aeruginosa causes serious nosocomial infections, and an important virulence factor produced by this organism is lipopolysaccharide (LPS). This review summarizes knowledge about biosynthesis of all three structural domains of LPS - lipid A, core oligosaccharide, and O polysaccharides. In addition, based on similarities with other bacterial species, this review proposes new hypothetical pathways for unstudied steps in the biosynthesis of P. aeruginosa LPS. Lipid A biosynthesis is discussed in relation to Escherichia coli and Salmonella, and the biosyntheses of core sugar precursors and core oligosaccharide are summarised. Pseudomonas aeruginosa attaches a Common Polysaccharide Antigen and O-Specific Antigen polysaccharides to lipid A-core. Both forms of O polysaccharide are discussed with respect to their independent synthesis mechanisms. Recent advances in understanding O-polysaccharide biosynthesis since the last major review on this subject, published nearly a decade ago, are highlighted. Since P. aeruginosa O polysaccharides contain unusual sugars, sugar-nucleotide biosynthesis pathways are reviewed in detail. Knowledge derived from detailed studies in the O5, O6 and O11 serotypes is applied to predict biosynthesis pathways of sugars in poorly-studied serotypes, especially O1, O4, and O13/O14. Although further work is required, a full understanding of LPS biosynthesis in P. aeruginosa is almost within reach.
Similar articles
-
Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides.Dev Biol Stand. 1990;71:121-6. Dev Biol Stand. 1990. PMID: 1698165
-
Polysaccharide antigens of Pseudomonas aeruginosa.Crit Rev Microbiol. 1990;17(4):273-304. doi: 10.3109/10408419009105729. Crit Rev Microbiol. 1990. PMID: 1698385 Review.
-
Conserved and variable structural features in the lipopolysaccharide of Pseudomonas aeruginosa.J Endotoxin Res. 2006;12(6):324-36. doi: 10.1179/096805106X118906. J Endotoxin Res. 2006. PMID: 17254386 Review.
-
Biosynthesis of uronamide sugars in Pseudomonas aeruginosa O6 and Escherichia coli O121 O antigens.Environ Microbiol. 2010 Jun;12(6):1531-44. doi: 10.1111/j.1462-2920.2010.02182.x. Epub 2010 Feb 25. Environ Microbiol. 2010. PMID: 20192967
-
Structural diversity of the core oligosaccharide domain of Pseudomonas aeruginosa lipopolysaccharide.Biochemistry (Mosc). 2011 Jul;76(7):755-60. doi: 10.1134/S0006297911070054. Biochemistry (Mosc). 2011. PMID: 21999536 Review.
Cited by
-
Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection.Nat Commun. 2021 Apr 28;12(1):2460. doi: 10.1038/s41467-021-22814-9. Nat Commun. 2021. PMID: 33911082 Free PMC article.
-
Systematic discovery of pseudomonad genetic factors involved in sensitivity to tailocins.ISME J. 2021 Aug;15(8):2289-2305. doi: 10.1038/s41396-021-00921-1. Epub 2021 Mar 1. ISME J. 2021. PMID: 33649553 Free PMC article.
-
The In Vivo and In Vitro Assessment of Pyocins in Treating Pseudomonas aeruginosa Infections.Antibiotics (Basel). 2022 Oct 7;11(10):1366. doi: 10.3390/antibiotics11101366. Antibiotics (Basel). 2022. PMID: 36290026 Free PMC article. Review.
-
Discovery of dual-activity small-molecule ligands of Pseudomonas aeruginosa LpxA and LpxD using SPR and X-ray crystallography.Sci Rep. 2019 Oct 29;9(1):15450. doi: 10.1038/s41598-019-51844-z. Sci Rep. 2019. PMID: 31664082 Free PMC article.
-
Microbe Profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat.Microbiology (Reading). 2020 Jan;166(1):30-33. doi: 10.1099/mic.0.000860. Microbiology (Reading). 2020. PMID: 31597590 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases